Healthtech Startups
17,191 companies tagged Healthtech, with their investors and founders.
0 investors
LinguaFlex develops a minimally-invasive, investigational device placed in the underside of the tongue to treat obstructive sleep apnea and snoring by keeping the airway open during sleep. The device is placed in a 10-minute outpatient procedure under light sedation and is being evaluated for patients with sleep apnea; it has not yet received FDA clearance in the US.
0 investors
Linus Health builds a digital cognitive assessment platform that applies AI to established cognitive tests to detect early signs of cognitive impairment and guide clinical action. It serves healthcare providers across care settings and life science researchers running clinical trials, in the brain health and cognitive care field.
0 investors
LIPAC Oncology is a pharmaceutical company developing chemotherapy treatments based on LiPax, a neoliposomal platform for local, targeted delivery of paclitaxel to treat intracavitary carcinomas. Its lead program targets non-muscle invasive bladder cancer, with additional indications in thoracic, upper tract urothelial, peritoneal, and ovarian cancers.
0 investors
Lipella Pharmaceuticals was a clinical-stage biotechnology company that developed therapies using a proprietary liposomal drug delivery platform, advancing candidates such as LP-10 and LP-310 through FDA-authorized Phase 2 trials in indications including oral lichen planus and hemorrhagic cystitis. The company ceased research and development activities in 2026 after a court-approved sale of its drug programs and intellectual property to XRAIY LLC, and the site now serves as a historical corporate archive.
0 investors
Lirio combines behavioral science and artificial intelligence to drive positive behavior change. The company operates a cloud-based AI platform designed to optimize outcomes through behavioral science principles.
0 investors
Lirum Therapeutics is a biopharmaceutical company that acquires, develops, and commercializes novel drug candidates for the treatment of difficult-to-treat, debilitating diseases. It was created by the former management team of Stemline Therapeutics.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Lixte develops cancer therapies, focusing on precision oncology and clinical drug development. The company works on advancing innovative treatments in the oncology field.
0 investors
0 investors
0 investors